(Q54580380)

English

Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response--the TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response--the TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

1 reference

based on heuristic

inferred from title

Pär I Johansson

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

9

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Thomas Engstrøm

12

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Steffen Helqvist

8

object named as

Steffen Helqvist

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

13

object named as

Lene Holmvang

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Peter Clemmensen

3

object named as

Peter Clemmensen

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Frants Pedersen

7

object named as

Frants Pedersen

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Nadia Paarup Dridi

1

object named as

Nadia Paarup Dridi

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Abbas Ali Qayyum

6

object named as

Abbas Qayyum

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

author name string

Trine Stissing

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Maria Dumitrela Radu

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Henning Kelbæk

10

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Erik Jørgensen

11

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

publication date

18 November 2013

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

25

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

7

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

506-512

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Platelet aggregation is dependent on platelet count in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Which is the best anticoagulant for whole blood aggregometry platelet function testing? Comparison of six anticoagulants and diverse storage conditions

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Autopsy validation study of the academic research consortium stent thrombosis definition

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Cytochrome P450 2B6 and 2C9 genotype polymorphism--a possible cause of prasugrel low responsiveness.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.845874

21 January 2018

Identifiers

10.3109/09537104.2013.845874

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/24245960

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54580380&oldid=1858439115"